The federal judge presiding over the Zoloft multidistrict litigation has adopted a special discovery master’s recommendation that Pfizer Inc. need not provide information about its internal communications about plaintiffs’ doctors just yet.
U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania said that, based upon her “careful and independent review,” she was adopting the master’s recommendation. In a filing from earlier this year, the plaintiff complained that the drug maker had not completely filled out fact sheets for each plaintiff. Those fact sheets list information and documents with respect to each plaintiff in the initial discovery pool.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
